ISDA

Deposition Date 2015-07-11

Release Date 2015-08-12

Last Version Date 2024-05-08

Entry Detail

PDB ID:

5A83

Keywords:

HYDROLASE

Title:

Crystal structure of human ATAD2 bromodomain in complex with 4-((3R, 4R)-4-3-methyl-5-(5-methylpyridin-3-yl)-2-oxo-1,2-dihydroquinolin-8- yl-aminopiperidin-3-yloxymethyl)-1-thiane-1,1-dione

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.09 Å

R-Value Free:

0.21

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 65 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2
Chain IDs:A
Chain Length:130
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:Q6PL18 Pfam ID:PF00439

Ligand Molecules

EDO

SO4

YD3

Primary Citation

Structure-Based Optimization of Naphthyridones Into Potent Atad2 Bromodomain Inhibitors.

Bamborough, P, Chung, C, Furze, R.C, Grandi, P, Michon, A, Sheppard, R.J, Barnett, H, Diallo, H, Dixon, D.P, Douault, C, Jones, E.J, Karamshi, B, Mitchell, D.J, Prinjha, R.K, Rau, C, Watson, R.J, Werner, T, Demont, E.H.Show

J.Med.Chem. 58 6151 ? (2015)

PMID: 26230603 DOI: 10.1021/ACS.JMEDCHEM.5B00773

Abstact

ATAD2 is a bromodomain-containing protein whose overexpression is linked to poor outcomes in a number of different cancer types. To date, no potent and selective inhibitors of the bromodomain have been reported. This article describes the structure-based optimization of a series of naphthyridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures